Advanced search
Publication Cover
Gynecological Endocrinology Volume 36, 2020 - Issue 10
Submit an article Journal homepage
157
Views
1
CrossRef citations to date
0
Altmetric
Ovarian Hyperstimulation Syndrome

Growth differentiation factor 9 inhibits vascular endothelial growth factor expression in human granulosa cells

Congcong GuoReproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; ;Guangdong Provincial Key Laboratory of Reproductive Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; ;Reproductive Medicine Center, Southern Medical University Affiliated Maternal and Child Health Hospital of Foshan, Foshan, ChinaView further author information
,
Minghui ChenReproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; ;Guangdong Provincial Key Laboratory of Reproductive Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; View further author information
,
Wenmin MaReproductive Medicine Center, Southern Medical University Affiliated Maternal and Child Health Hospital of Foshan, Foshan, ChinaView further author information
,
Bing CaiReproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; ;Guangdong Provincial Key Laboratory of Reproductive Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; View further author information
,
Yanwen XuReproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; ;Guangdong Provincial Key Laboratory of Reproductive Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; View further author information
,
Yiping ZhongReproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; ;Guangdong Provincial Key Laboratory of Reproductive Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; View further author information
&
Canquan ZhouReproductive Medicine Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; ;Guangdong Provincial Key Laboratory of Reproductive Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Correspondence[email protected]
View further author information
 show all
Pages 907-911 | Received 12 Nov 2018, Accepted 16 Jan 2020, Published online: 30 Jan 2020

References

  • Soares SR. Etiology of OHSS and use of dopamine agonists. Fertil Steril. 2012;97(3):517–522.
  • Wang TH, Horng SG, Chang CL, et al. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab. 2002;87(7):3300–3308.
  • Gille H, Kowalski J, Li B, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem. 2001;276(5):3222–3230.
  • Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol. 2002;39(4–5):225–237.
  • McClure N, Healy DL, Rogers PA, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet. 1994;344(8917):235–236.
  • Gómez R, Simón C, Remohí J, et al. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology. 2002;143(11):4339–4348.
  • Shao ES, Lin L, Yao Y, et al. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood. 2009;114(10):2197–2206.
  • Dong J, Albertini DF, Nishimori K, et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383(6600):531–535.
  • Vitt UA, Mazerbourg S, Klein C, et al. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol Reprod. 2002;67(2):473–480.
  • Mazerbourg S, Klein C, Roh J, et al. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol. 2004;18(3):653–665.
  • Jiang Z, Yu Q, Xia L, et al. Growth differentiation Factor-9 promotes fibroblast proliferation and migration in keloids through the smad2/3 pathway. Cell Physiol Biochem. 2016;40(1–2):207–218.
  • Kuo SW, Ke FC, Chang GD, et al. Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGFβ1) in the regulation of ovarian angiogenesis. J Cell Physiol. 2011;226(6):1608–1619.
  • Yu YX, Xiu YL, Chen X, et al. Transforming growth factor-beta 1 involved in the pathogenesis of endometriosis through regulating expression of vascular endothelial growth factor under hypoxia. Chin Med J (Engl). 2017;130(8):950–956.
  • Seystahl K, Tritschler I, Szabo E, et al. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma. Neuro Oncol. 2015;17(2):254–265.
  • Miller I, Chuderland D, Ron-El R, et al. GnRH agonist triggering modulates PEDF to VEGF ratio inversely to hCG in granulosa cells. J Clin Endocrinol Metab. 2015;100(11):E1428–36.
  • Basu S, Nagy JA, Pal S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001;7(5):569–574.
  • Gomez R, Gonzalez-Izquierdo M, Zimmermann RC, et al. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology. 2006;147(11):5400–5411.
  • Tang H, Mourad S, Zhai SD, et al. Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2016;11:CD008605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.